Takeda Pharmaceutical (TAK) Treasury Shares: 2018-2025

  • Takeda Pharmaceutical's Treasury Shares rose 41.78% to $490.4 million in Q1 2025 from the same period last year, while for Mar 2025 it was $490.4 million, marking a year-over-year increase of 41.78%. This contributed to the annual value of $491.1 million for FY2025, which is 38.18% up from last year.
  • Takeda Pharmaceutical's Treasury Shares amounted to $490.4 million in Q1 2025, which was up 41.78% from $345.9 million recorded in Q1 2024.
  • Takeda Pharmaceutical's 5-year Treasury Shares high stood at $998.2 million for Q1 2022, and its period low was $345.9 million during Q1 2024.
  • In the last 3 years, Takeda Pharmaceutical's Treasury Shares had a median value of $209,918 in 2023 and averaged $202,482.
  • As far as peak fluctuations go, Takeda Pharmaceutical's Treasury Shares dropped by 27.97% in 2021, and later soared by 122.93% in 2022.
  • Takeda Pharmaceutical's Treasury Shares (Quarterly) stood at $562.6 million in 2021, then skyrocketed by 77.42% to $998.2 million in 2022, then dropped by 24.03% to $758.4 million in 2023, then plummeted by 54.39% to $345.9 million in 2024, then spiked by 41.78% to $490.4 million in 2025.
  • Its last three reported values are $490.4 million in Q1 2025, $345.9 million for Q1 2024, and $758.4 million during Q1 2023.